Milliman Risk Score 2.0 – Stratifying Mortality Risk Using Prescription Drug Information
Munich Re assessed the Milliman Rx Risk Score, a predictive modeling tool developed and owned by Milliman that assesses mortality risk using an individual’s prescription drug information. Insurers considering prescription- drug-based scores should begin with a retrospective validation study on their own experience data.
Milliman IntelliScript Underwriting with Rx Based Models (Slides)
Slides from this presentation, given at the 2018 ACSW Spring Meeting, have been posted at the Actuaries’ Club of the Southwest website.
Presentations from the 2018 WAHLU Spring Seminar
Slides from the 2018 Wisconsin Association of Health and Life Underwriters have been posted at the WAHLU website.
- Drugs: Startling trends, testing & tales
- Underwriting Asthma & COPD Using Rx
- Underwriting Alcohol-Related Risk
For New Antipsychotic Users, Dose, Duration Impact Mortality
Dose and duration of therapy are associated with mortality for new antipsychotic users, according to a study published online May 10 in the Journal of the American Geriatrics Society.